Agility Life Sciences, an award-winning formulation development CDMO based in Nottingham, UK, and Solitek, experts in solid state development services for the pharmaceutical, agrochemical and fine chemical industries based in Barcelona, Spain, have entered into a Strategic Partnership agreement in order to accelerate the pharmaceutical development milestones of their clients.
The agreement will see Agility Life Sciences signpost and recommend Solitek’s solid state
services to clients, with Solitek reciprocally promoting Agility’s formulation development
services. The two organisations have also agreed to provide training on their products and
services, as well as offering technical support and client liaison.
Agility Life Sciences CEO, Prof. Claire Thompson, commented: “I am thrilled to sign our first
Strategic Partnership agreement with Solitek, who have a combined experience of nearly 50 years in the pharmaceutical industry, including over 40 years in the world of solid state
research and crystallisation development. Partnerships are vital in this industry, and I am
confident that both companies will strengthen each other’s client base in a mutually beneficial arrangement. I am excited to begin this new chapter of collaboration.”
Solitek co-founder and Operations Director, Víctor Díaz, added: “This partnership is a critical steppingstone in our ambition to offer a full preclinical development services portfolio. Having worked with Claire before, I am convinced that Agility Life Sciences are the right partners to learn and to grow with. Solitek and Agility Life Sciences form a very strong partnership with a level of specialisation and expertise difficult to match.”
